Comparison · NCT01976936-810c4e52
Standard vs High Dose: Total Number of Participants With a Barthel Index Score > 95
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Standard vs High Dose: Total Number of Participants With a Barthel Index Score > 95. Trial comparisons, record NCT01976936-810c4e52. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01976936-810c4e52
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.708 | 0.588 | 0.804 | wilson | |
| Risk in group 2 | 0.543 | 0.427 | 0.654 | wilson | |
| Risk difference, group 1 minus group 2 | 0.165 | 0.00134 | 0.316 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.3 | 0.999 | 1.7 | log | |
| Odds ratio, group 1 over group 2 | 2.04 | 1 | 4.15 | log | |
| Number needed to treat, for one more participant with the outcome on Standard than on High Dose | 6.07 | 3.17 | 745 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Standard | Includes individuals on placebo or 80mg of Lovastatin | 46 | 65 | OG000 |
| Group 2 | High Dose | Includes individuals on 640mg of Lovastatin | 38 | 70 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Total Number of Participants With a Barthel Index Score > 95
- Description
The Barthel Index will be used to measure functional outcomes by counting the total number of individuals with a Barthel index score greater than or equal to 95. Numerical scores based on whether an individual requires physical assistance to perform the task or can complete it independently. An individual scoring 0 points would be dependent in all assessed activities of daily living, whereas a score of 100 would reflect independence in these activities, indicative of a better outcome.
- Time frame
- 90 days
- Population
- Only includes individuals who completed Barthel Index.
Source ClinicalTrials.gov
Trial
- Title
- Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
- NCT number
- NCT01976936
- Phases
- PHASE2
- Conditions
- Stroke, Rhabdomyolysis, Jaundice
- Interventions
- Low Dose Lovastatin, Placebo, High Dose Lovastatin
- Lead sponsor
- Columbia University
- Results first posted
- 2025-12-01
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01976936?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01976936-810c4e52